Experienced in Stomach Cancer

Dr. Kinsey A. Mccormick

Oncology
1221 Madison Street, Floor 5, 
Seattle, WA 
Accepting New Patients
Offers Telehealth
Experienced in Stomach Cancer
1221 Madison Street, Floor 5, 
Seattle, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kinsey Mccormick is an Oncologist in Seattle, Washington. Dr. Mccormick is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Mccormick is currently accepting new patients.

Her clinical research consists of co-authoring 5 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Stomach Cancer.

Specialties
Oncology
Licenses
Internal Medicine in WA
Hospital Affiliations
University Of Washington Medical Ctr
Swedish Medical Center / Cherry Hill
Swedish Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Lifewise

Accepted plan types not found. Please verify directly with the provider.

Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Prominence Health
  • EPO
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

1221 Madison Street, Floor 5, Seattle, WA 98104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Procedure, Drug
Study Drugs: Atezolizumab, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 3
View 1 Less Clinical Trial

5 Total Publications

Grade Assignment by Ki-67 Proliferative Index, Mitotic Count, and Phosphohistone H3 Count in Surgically Resected Gastrointestinal and Pancreatic Neuroendocrine Tumors.
Grade Assignment by Ki-67 Proliferative Index, Mitotic Count, and Phosphohistone H3 Count in Surgically Resected Gastrointestinal and Pancreatic Neuroendocrine Tumors.
Journal: Pancreas
Published: October 18, 2017
Similar Doctors
Veena Shankaran
Distinguished in Stomach Cancer
Dr. Veena Shankaran
Oncology
Distinguished in Stomach Cancer
Dr. Veena Shankaran
Oncology

The Association Of University Physicians

1701 Columbia Rd, 
Seattle, WA 
 (2.8 miles away)
206-598-3100
Languages Spoken:
English, Castilian, French, Malay, Portuguese, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Veena Shankaran is an Oncologist in Seattle, Washington. Dr. Shankaran is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Colorectal Cancer, Stomach Cancer, Familial Colorectal Cancer, Colonoscopy, and Endoscopy. Dr. Shankaran is currently accepting new patients.

Advanced in Stomach Cancer
Dr. Philip J. Gold
Oncology
Advanced in Stomach Cancer
Dr. Philip J. Gold
Oncology
1221 Madison Street, Arnold Pavilion, Suite 200, 
Seattle, WA 
 (0.1 miles away)
206-386-2121
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Philip Gold is an Oncologist in Seattle, Washington. Dr. Gold is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Neuroendocrine Tumor, and Lynch Syndrome. Dr. Gold is currently accepting new patients.

Distinguished in Stomach Cancer
Dr. David B. Zhen
Hematology Oncology | Hematology | Oncology
Distinguished in Stomach Cancer
Dr. David B. Zhen
Hematology Oncology | Hematology | Oncology

The Association Of University Physicians

825 Eastlake Ave E, 
Seattle, WA 
 (1.2 miles away)
206-288-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Zhen is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Zhen is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Pancreatic Cancer, Stomach Cancer, Neuroendocrine Tumor, and Familial Pancreatic Cancer. Dr. Zhen is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mccormick's expertise for a condition
ConditionClose
    View All 32 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile